Lornoxicam tablets bulk supplier for pharma manufacturers

Lornoxicam Tablets 4 mg, 8 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 4 mg, 8 mg

Reference Brands: Xefo (EU)

Category: Analgesic

Lornoxicam 4 mg and 8 mg tablets, a short half-life oxicam NSAID for acute pain and arthritis, registered in several European and Asian markets but not the US, for importers, distributors and hospitals.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Lornoxicam Tablets? List it or send an offer →

Product Description:

Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam family, chemically close to tenoxicam. It inhibits both COX-1 and COX-2, cutting prostaglandin production and so easing pain and inflammation. Unlike piroxicam, it has a short half-life of a few hours, so it is dosed two or three times a day and suits acute pain as well as longer courses. This page covers 4 mg and 8 mg film-coated tablets; the injection and quick-release tablet are separate products.

Approved uses are short-term relief of mild to moderate acute pain, such as after surgery, and symptomatic relief in osteoarthritis and rheumatoid arthritis. The usual dose is 8 to 16 mg a day in divided doses, swallowed with liquid, keeping to the smallest effective dose for the shortest time. NSAID class warnings apply: gastrointestinal bleeding, cardiovascular and renal risk, and avoidance in late pregnancy and severe heart failure. Pharmacists check for anticoagulants, SSRIs, ACE inhibitors, diuretics, lithium and methotrexate, and older patients often need gastroprotection.

Sourcing notes. Lornoxicam is not approved in the United States. It is authorised nationally in several European countries and registered in India and a number of other markets, so confirm registration in the destination. It is prescription-only. Expect a CTD or ACTD dossier, with bioequivalence data where required and zone IVb stability data for hot humid markets. Tablets are blister-packed and kept dry, with no cold chain. Ask for a CoA per batch with assay and dissolution, plus GMP certificate and CoPP. Combinations with paracetamol also circulate, so check that any combination is approved in your market.

Lornoxicam Tablets — third party manufacturing & bulk supply

Lornoxicam Tablets 4 mg, 8 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lornoxicam Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lornoxicam Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lornoxicam Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Lornoxicam is used to relieve pain, inflammation, and swelling in conditions such as osteoarthritis, rheumatoid arthritis, and postoperative or acute musculoskeletal pain.

Lornoxicam is made from the active ingredient lornoxicam, an oxicam-class non-steroidal anti-inflammatory drug (NSAID), along with standard pharmaceutical excipients based on the manufacturer’s formulation.

Common trade names include Xefo and Lornoxicam (regional branded generics).

Lornoxicam is manufactured by several pharmaceutical companies globally, including manufacturers in the EU, UK, and other regulated markets.

The generic name is lornoxicam.

Well-known brand names include Xefo and various regional branded generics.

It is manufactured in multiple countries worldwide, including regions across Europe, the UK, and other approved global pharmaceutical manufacturing locations.